Intragastric acidity under 28-day omeprazole treatment

Area of Science:

• Gastroenterology
• Pharmacology

Background:

• Gastric acid activity is crucial for digestion but elevated levels can cause issues.
• Omeprazole is a proton pump inhibitor used to reduce stomach acid production.

Purpose of the Study:

• To evaluate the impact of a 28-day omeprazole treatment on 24-hour intragastric acidity.
• To assess the effect of repeated intragastric investigations on acid activity.

Main Methods:

• A double-blind, randomized study involving 10 healthy subjects receiving omeprazole (30 mg daily) and 5 receiving a placebo.
• Intragastric acidity was measured at multiple time points before, during, and after the treatment period.

Main Results:

• Omeprazole treatment resulted in a 90% reduction in 24-hour acid concentration and an 85% decrease in nocturnal acidity.
• No rebound hyperacidity was observed after drug withdrawal.
• Repeated investigations at short intervals led to a significant increase in baseline 24-hour intragastric H+ activity.

Conclusions:

• Omeprazole (30 mg daily) effectively inhibits both daytime and nighttime gastric acid production.
• Frequent diagnostic procedures may inadvertently stimulate gastric acid secretion.